Weighted Average Number of Shares Outstanding, Basic of GUIDED THERAPEUTICS INC from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
GUIDED THERAPEUTICS INC quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • GUIDED THERAPEUTICS INC Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 81,689,000.
  • GUIDED THERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 32,505,000.
  • GUIDED THERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 13,377,000, a 24% increase from 2020.
  • GUIDED THERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 10,767,000, a 325975% increase from 2019.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

GUIDED THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 81,689,000* +81,631,961 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q3 2024 57,039 +5,566 +11% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2023 51,473 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q4 2021 13,377,000 +2,610,000 +24% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 13,417,000 +422,000 +3.2% 01 Jul 2021 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 13,280,000 +1,367,000 +11% 01 Apr 2021 30 Jun 2021 10-Q 18 Aug 2021 2021 Q2
Q1 2021 13,172 +8,159 +163% 01 Jan 2021 31 Mar 2021 10-Q/A 18 Aug 2021 2021 Q1
Q4 2020 10,767,000 +10,763,698 +325975% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 12,995,000 +12,991,681 +391434% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 11,913,000 +11,909,716 +362659% 01 Apr 2020 30 Jun 2020 10-Q 18 Aug 2021 2021 Q2
Q1 2020 5,013 +1,765 +54% 01 Jan 2020 31 Mar 2020 10-Q/A 18 Aug 2021 2021 Q1
Q4 2019 3,302 +2,840 +615% 01 Oct 2019 31 Dec 2019 10-K 07 Apr 2021 2020 FY
Q3 2019 3,319 +2,925 +742% 01 Jul 2019 30 Sep 2019 10-Q/A 05 Nov 2020 2020 Q3
Q2 2019 3,284 +3,038 +1235% 01 Apr 2019 30 Jun 2019 10-Q 20 Aug 2020 2020 Q2
Q1 2019 3,248 +3,137 +2826% 01 Jan 2019 31 Mar 2019 10-Q 07 Jul 2020 2020 Q1
Q4 2018 462 01 Oct 2018 31 Dec 2018 10-K 20 Apr 2020 2019 FY
Q3 2018 394 -6,490 -94% 01 Jul 2018 30 Sep 2018 10-Q 09 Mar 2020 2019 Q3
Q2 2018 246 -1,670 -87% 01 Apr 2018 30 Jun 2018 10-Q 11 Feb 2020 2019 Q2
Q1 2018 111 -835 -88% 01 Jan 2018 31 Mar 2018 10-Q 11 Jul 2019 2019 Q1
Q3 2017 6,884 +6,601 +2333% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 1,916 -39,084 -95% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 946 -2,138 -69% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018 2018 Q1
Q4 2016 203 01 Oct 2016 31 Dec 2016 10-K/A 20 Apr 2018 2017 FY
Q3 2016 283 +281 01 Jul 2016 30 Sep 2016 10-Q 20 Nov 2017 2017 Q3
Q2 2016 41,000 -66,256 -62% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017 2017 Q2
Q1 2016 3,084 +2,111 +217% 01 Jan 2016 31 Mar 2016 10-Q 19 May 2016 2016 Q1
Q3 2015 2* -77,649 01 Jul 2015 30 Sep 2015 10-Q 05 Dec 2016 2016 Q3
Q2 2015 107,256 +34,270 +47% 01 Apr 2015 30 Jun 2015 10-Q 17 Aug 2016 2016 Q2
Q1 2015 973 -70,478 -99% 01 Jan 2015 31 Mar 2015 10-Q 19 May 2016 2016 Q1
Q4 2014 771 -65,113 -99% 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 77,651 +11,390 +17% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 72,986 +7,311 +11% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015 2015 Q2
Q1 2014 71,451 +7,780 +12% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015 2015 Q1
Q4 2013 65,884 +8,455 +15% 01 Oct 2013 31 Dec 2013 10-K 25 Mar 2015 2014 FY
Q3 2013 66,261 +5,434 +8.9% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 65,675 +11,598 +21% 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014 2014 Q2
Q1 2013 63,671 +11,200 +21% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q4 2012 57,429 +8,561 +18% 01 Oct 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
Q3 2012 60,827 +12,014 +25% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q2 2012 54,077 +5,613 +12% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q1 2012 52,471 +4,620 +9.7% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q4 2011 48,868 01 Oct 2011 31 Dec 2011 10-K 27 Mar 2013 2012 FY
Q3 2011 48,813 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3
Q2 2011 48,464 +15,944 +49% 01 Apr 2011 30 Jun 2011 10-Q/A 24 Aug 2012 2012 Q2
Q1 2011 47,851 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012 2012 Q1
Q2 2010 32,520 01 Apr 2010 30 Jun 2010 10-Q 14 Nov 2011 2011 Q2

GUIDED THERAPEUTICS INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 32,505,000* +19,128,000 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
2021 13,377,000 +2,610,000 +24% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 10,767,000 +10,763,698 +325975% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 3,302 +2,840 +615% 01 Jan 2019 31 Dec 2019 10-K 07 Apr 2021 2020 FY
2018 462 +451 01 Jan 2018 31 Dec 2018 10-K 20 Apr 2020 2019 FY
2017 11* -192 01 Jan 2017 31 Dec 2017 10-K 08 May 2019 2018 FY
2016 203 +201 01 Jan 2016 31 Dec 2016 10-K/A 20 Apr 2018 2017 FY
2015 2* -769 01 Jan 2015 31 Dec 2015 10-K 22 Mar 2017 2016 FY
2014 771 -65,113 -99% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2016 2015 FY
2013 65,884 +8,455 +15% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2015 2014 FY
2012 57,429 +8,561 +18% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
2011 48,868 +10,272 +27% 01 Jan 2011 31 Dec 2011 10-K 27 Mar 2013 2012 FY
2010 38,596 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.